Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2074)
All Articles published online
|
Jun 21, 2005 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen YQ, Zhang JQ, Miao FQ, Zhang JM, Jiang Q, Chen H, Shan XN, Xie W. Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer. World J Gastroenterol 2005; 11(23): 3628-3631 [PMID: 15962390 DOI: 10.3748/wjg.v11.i23.3628] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i23/3628.htm |
| Number | Citing Articles |
| 1 |
Q. Ye, Y. Shen, X. Wang, J. Yang, F. Miao, C. Shen, J. Zhang. Hypermethylation of HLA class I gene is associated with HLA class I down‐regulation in human gastric cancer. Tissue Antigens 2010; 75(1): 30 doi: 10.1111/j.1399-0039.2009.01390.x
|
| 2 |
Hae-Wan Lee, Soo Kee Min, Young-Su Ju, Joohon Sung, Man Sup Lim, Dae Hyun Yang, Bong Hwa Lee. Prognostic Significance of HLA Class I Expressing in Gastric Carcinoma Defined by Monoclonal Anti-Pan HLA Class I Antibody, EMR8-5. Journal of Gastrointestinal Surgery 2011; 15(8): 1336 doi: 10.1007/s11605-011-1545-3
|
| 3 |
Shen‐Kang Zhou, Lei‐Lei Yang, Rui Chen, Yong Lu, Yong‐Hua Zheng. HLA‐DQB1*03 genotype and perioperative blood transfusion are not conducive to the prognosis of patients with gastric cancer. Journal of Clinical Laboratory Analysis 2018; 32(7) doi: 10.1002/jcla.22443
|
| 4 |
GENTARO ITO, HIROAKI TANAKA, MASAICHI OHIRA, MAMI YOSHII, KAZUYA MUGURUMA, NAOSHI KUBO, MASAKAZU YASHIRO, NOBUYA YAMADA, KIYOSHI MAEDA, TETSUJI SAWADA, KOSEI HIRAKAWA. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Experimental and Therapeutic Medicine 2012; 3(6): 925 doi: 10.3892/etm.2012.537
|
| 5 |
Kazuto Nishio, Tokuzo Arao, Terufumi Kato, Hideyuki Yokote. EGFR mutation in various tissues. Cancer Chemotherapy and Pharmacology 2006; 58(S1): 39 doi: 10.1007/s00280-006-0314-6
|
| 6 |
Hiroaki Saito, Seigo Takaya, Tomohiro Osaki, Masahide Ikeguchi. Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients. Gastric Cancer 2013; 16(4): 473 doi: 10.1007/s10120-012-0210-1
|
| 7 |
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.636568
|
| 8 |
Yoshitake Ueda, Koichi Ishikawa, Norio Shiraishi, Shigeo Yokoyama, Seigo Kitano. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer. Journal of Surgical Oncology 2008; 97(5): 451 doi: 10.1002/jso.20985
|
| 9 |
Federico Garrido. MHC Class-I Loss and Cancer Immune Escape. Advances in Experimental Medicine and Biology 2019; 1151: 15 doi: 10.1007/978-3-030-17864-2_2
|
| 10 |
Jian-Gang Zhang, Xia Zhang, Aifen Lin, Wei-Hua Yan. Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer. Human Immunology 2013; 74(7): 828 doi: 10.1016/j.humimm.2013.03.002
|
| 11 |
Arfon G. M. T. Powell, Paul G. Horgan, Joanne Edwards. The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?. Journal of Cancer Research and Clinical Oncology 2012; 138(5): 723 doi: 10.1007/s00432-012-1192-4
|
| 12 |
Hiroaki Saito, Tomohiro Osaki, Masahide Ikeguchi. Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. Gastric Cancer 2012; 15(1): 27 doi: 10.1007/s10120-011-0059-8
|
| 13 |
Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee. Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer. Cancer Immunology, Immunotherapy 2019; 68(11): 1779 doi: 10.1007/s00262-019-02410-z
|